Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.

Hunsicker, OScott, MJMiller, TEBaldini, GFeldheiser, A2017-04-062017-04-062015-07https://hdl.handle.net/10161/13952ColloidsColorectal SurgeryFemaleFluid TherapyHumansHydroxyethyl Starch DerivativesIsotonic SolutionsMaleGastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.Journal article1471-6771